Table 1 Outcomes and measurements of the effect and economic evaluation

Patient characteristics

Checking inclusion & exclusion criteria

x

Severity of urinary incontinence (ICIQ-UI SF)

x

x

x

x

Health-related quality of life (EQ-5D-5 L)

x

x

x

x

Urogenital distress (UDI-6)

x

x

x

x

Improvement of UI (PGI-I)

x

x

x

Depressive symptoms (CES-D)

x

x

x

x

use of absorbent products (in accordance with the recommended criteria in guidelines) (yes/no)

x

x

x

x

Costs (retrospective)

 questions based on TICP (past period)

x

x

x

 pharmacist data (past 12 months)

x